QUEENSBURY, N.Y.--(BUSINESS WIRE)--AngioDynamics (NASDAQ:ANGO), a leading provider of innovative medical devices for the minimally-invasive treatment of cancer and peripheral vascular disease, announced today that it will report its fiscal 2010 third quarter financial results on Thursday, April 1, 2010, after the close of the financial markets.
